Cargando…
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
RYBP is a member of the polycomb group (PcG) proteins that typically act as transcriptional repressors via epigenetic modification of chromatin. The present study was designed to investigate the role of RYBP in HCC progression, chemosensitivity, and patient survival, and to explore the underlying mo...
Autores principales: | Wang, Wei, Cheng, Jianwen, Qin, Jiang-Jiang, Voruganti, Sukesh, Nag, Subhasree, Fan, Jia, Gao, Qiang, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294343/ https://www.ncbi.nlm.nih.gov/pubmed/25344099 |
Ejemplares similares
-
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
por: Voruganti, Sukesh, et al.
Publicado: (2015) -
Natural Product Ginsenoside 25-OCH(3)-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
por: Wang, Wei, et al.
Publicado: (2012) -
Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011) -
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023) -
Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
por: Qin, Jiang-Jiang, et al.
Publicado: (2014)